(Q52863050)

9 May 2018

title

Role of antibody response in outcome of antibiotic-associated diarrhoea. (English)

1 reference

9 May 2018

0 references

1 reference

M Wilcox

1

1 reference

9 May 2018

J Minton

series ordinal

2

1 reference

9 May 2018

language of work or name

English

0 references

publication date

1 January 2001

1 reference

9 May 2018

published in

The Lancet

1 reference

9 May 2018

volume

357

1 reference

9 May 2018

issue

9251

1 reference

9 May 2018

page(s)

158-159

1 reference

9 May 2018

Factors associated with prolonged symptoms and severe disease due to Clostridium difficile

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903582-0

7 January 2021

Financial burden of hospital-acquired Clostridium difficile infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903582-0

7 January 2021

Recurrence of symptoms in Clostridium difficile infection--relapse or reinfection?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903582-0

7 January 2021

Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903582-0

7 January 2021

Serum antibody response to toxins A and B of Clostridium difficile

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903582-0

7 January 2021

Human antibody response to Clostridium difficile toxin A in relation to clinical course of infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903582-0

7 January 2021

Primary symptomless colonisation by Clostridium difficile and decreased risk of subsequent diarrhoea

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903582-0

7 January 2021

Polymeric IgA is superior to monomeric IgA and IgG carrying the same variable domain in preventing Clostridium difficile toxin A damaging of T84 monolayers

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903582-0

7 January 2021

Intravenous immunoglobulin therapy for severe Clostridium difficile colitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903582-0

7 January 2021

Hospital-acquired Clostridium difficile diarrhoea and herd immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2903582-0

7 January 2021

10.1016/S0140-6736(00)03582-0

Identifiers

DOI

1 reference

9 May 2018

PubMed ID

11213086

1 reference

9 May 2018